Latest filing published 22 Mar 2019 for Codexis, INC., €119k.
Gordon Sangster discloses dealings in 2 companies, chiefly Codexis, Inc. and Micrus Endovascular Corp. We count 27 filings; the first trade dates from 27 September 2010 and the latest from 21 March 2019.
No open-market purchase appears, only 9 sales worth €4.2M. Other entries cover 9 share grants and 8 option exercises. 2019 to date brings no purchases and 4 sales.
The latest filing, published on 22 March 2019, reports an open-market sale of €734k in Codexis, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations